There was no association between the nuclear to cytoplasmic ratio of SBP1 and prostate cancer recurrence.

Odds ratios (OR) and 95% confidence intervals (CI) for prostate cancer recurrence by quartile of nuclear to cytoplasmic SBP1 expression. Expression level was measured by the VECTRA quantitative imaging system, and all OR estimates are adjusted for PSA, Gleason grade, tumor stage, and patient age at diagnosis. There was no association between the nuclear to cytoplasmic ratio of SBP1 and prostate cancer recurrence.